scholarly journals Rotational thromboelastometry (ROTEM) – The future of haemostatic resuscitation in major trauma centres

2014 ◽  
Vol 12 ◽  
pp. S89
Author(s):  
Ruth Bird ◽  
James Lawless ◽  
Ross Davenport ◽  
Claire Rourke ◽  
Anne Weaver ◽  
...  
2017 ◽  
Vol 126 (1) ◽  
pp. 115-127 ◽  
Author(s):  
Ross A. Davenport ◽  
Maria Guerreiro ◽  
Daniel Frith ◽  
Claire Rourke ◽  
Sean Platton ◽  
...  

Abstract Background Major trauma is a leading cause of morbidity and mortality worldwide with hemorrhage accounting for 40% of deaths. Acute traumatic coagulopathy exacerbates bleeding, but controversy remains over the degree to which inhibition of procoagulant pathways (anticoagulation), fibrinogen loss, and fibrinolysis drive the pathologic process. Through a combination of experimental study in a murine model of trauma hemorrhage and human observation, the authors’ objective was to determine the predominant pathophysiology of acute traumatic coagulopathy. Methods First, a prospective cohort study of 300 trauma patients admitted to a single level 1 trauma center with blood samples collected on arrival was performed. Second, a murine model of acute traumatic coagulopathy with suppressed protein C activation via genetic mutation of thrombomodulin was used. In both studies, analysis for coagulation screen, activated protein C levels, and rotational thromboelastometry (ROTEM) was performed. Results In patients with acute traumatic coagulopathy, the authors have demonstrated elevated activated protein C levels with profound fibrinolytic activity and early depletion of fibrinogen. Procoagulant pathways were only minimally inhibited with preservation of capacity to generate thrombin. Compared to factors V and VIII, proteases that do not undergo activated protein C–mediated cleavage were reduced but maintained within normal levels. In transgenic mice with reduced capacity to activate protein C, both fibrinolysis and fibrinogen depletion were significantly attenuated. Other recognized drivers of coagulopathy were associated with less significant perturbations of coagulation. Conclusions Activated protein C–associated fibrinolysis and fibrinogenolysis, rather than inhibition of procoagulant pathways, predominate in acute traumatic coagulopathy. In combination, these findings suggest a central role for the protein C pathway in acute traumatic coagulopathy and provide new translational opportunities for management of major trauma hemorrhage.


2017 ◽  
Vol 16 (3) ◽  
pp. e1184
Author(s):  
M. Hadjipavlou ◽  
E. Grouse ◽  
R. Gray ◽  
C. Brown ◽  
D. Sharma

Injury ◽  
2019 ◽  
Vol 50 (9) ◽  
pp. 1534-1539 ◽  
Author(s):  
Matthew S. Dunn ◽  
Ben Beck ◽  
Pam M. Simpson ◽  
Peter A. Cameron ◽  
Marcus Kennedy ◽  
...  

2020 ◽  
Vol 9 (8) ◽  
pp. 2420
Author(s):  
Helmuth Tauber ◽  
Nicole Innerhofer ◽  
Daniel von Langen ◽  
Mathias Ströhle ◽  
Dietmar Fries ◽  
...  

Although platelets play a central role in haemostasis, the dynamics of platelet counts during haemostatic resuscitation, the response to platelet transfusion, and effects on clinical outcome are poorly described for trauma patients. As a sub-study of the already published randomized controlled RETIC Study “Reversal of Trauma-induced Coagulopathy using First-line Coagulation Factor Concentrates or Fresh-Frozen Plasma” trial, we here analysed whether the type of first-line haemostatic resuscitation influences the frequency of platelet transfusion and determined the effects of platelet transfusion in coagulopathic patients with major trauma. Patients randomly received first-line plasma (FFP) or coagulation factor concentrates (CFC), mainly fibrinogen concentrate. In both groups, platelets were transfused to maintain platelet counts between 50 and 100 × 109/L. Transfusion rates were significantly higher in the FFP (n = 44) vs. CFC (n = 50) group (FFP 47.7% vs. CFC 26%); p = 0.0335. Logistic regression analysis adjusted for the stratification variables injury severity score (ISS) and brain injury confirmed that first-line FFP therapy increases the odds for platelet transfusion (odds ratio (OR) 5.79 (1.89 to 20.62), p = 0.0036) and this effect was larger than a 16-point increase in ISS (OR 4.33 (2.17 to 9.74), p = 0.0001). In conclusion, early fibrinogen supplementation exerted a platelet-saving effect while platelet transfusions did not substantially improve platelet count and might contribute to poor clinical outcome.


2011 ◽  
Vol 96 (Supplement 1) ◽  
pp. Fa120-Fa121 ◽  
Author(s):  
K. S. King ◽  
S. Setty ◽  
K. Thompson ◽  
A. P. McGlennan ◽  
A. L. Wright

Burns ◽  
2013 ◽  
Vol 39 (7) ◽  
pp. 1495
Author(s):  
Dariush Nikkhah ◽  
Baljit Dheansa

Sign in / Sign up

Export Citation Format

Share Document